RESUMEN
In Sweden there are several reports of mares developing acute colitis while their foals were being treated orally for Rhodococcus equi pneumonia with the combination of erythromycin and rifampicin. In this study 6 adult horses were given low oral dosages of these antibiotics, singly or in combination. Within 3 days post administration of erythromycin, in one case in combination with rifampicin, 2 horses developed severe colitis (one fatal). Clostridium difficile was isolated from one of the horses, whereas no specific pathogens were isolated from the other. Both horses had typical changes in blood parameters seen in acute colitis. Clostridium difficile was also isolated from the faeces of a third horse given an even lower dosage of erythromycin in combination with rifampicin. This horse developed very mild clinical symptoms and recovered spontaneously. In the fourth horse given erythromycin only, very high numbers of Clostridium perfringens were isolated. The horses given rifampicin only did not develop any clinical symptoms and there were no major changes in their faecal flora. In conclusion, it has been demonstrated that low dosages of erythromycin ethylsuccinate can induce severe colitis in horses associated with major changes of the intestinal microflora. Clostridium difficile has been demonstrated as a potential aetiological agent in antibiotic-induced acute colitis.
Asunto(s)
Antibacterianos/efectos adversos , Clostridioides difficile/aislamiento & purificación , Enterocolitis Seudomembranosa/veterinaria , Etilsuccinato de Eritromicina/efectos adversos , Enfermedades de los Caballos/microbiología , Infecciones por Actinomycetales/tratamiento farmacológico , Infecciones por Actinomycetales/veterinaria , Enfermedad Aguda , Animales , Animales Lactantes , Antibacterianos/administración & dosificación , Clostridioides difficile/crecimiento & desarrollo , Enterocolitis Seudomembranosa/inducido químicamente , Enterocolitis Seudomembranosa/microbiología , Etilsuccinato de Eritromicina/administración & dosificación , Heces/microbiología , Femenino , Enfermedades de los Caballos/inducido químicamente , Caballos , Masculino , Rhodococcus equi/efectos de los fármacos , Rifampin/administración & dosificación , Rifampin/efectos adversos , SueciaRESUMEN
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of benzylpenicillin (PEN) and dihydrostreptomycinsulfate (DHS) were determined for freshly isolated bovine udder pathogens. Killing curves were determined to study synergism of PEN and DHS on Staphylococcus aureus and Streptococcus uberis. Healthy udder quarters of cows in their first lactation were inoculated with Str dysgalactiae or Str uberis strains. After development of acute mastitis, procaine PEN alone or combined with DHS were given IM, and the concentrations of PEN and DHS in plasma and normal and mastitic milk were determined. Twenty-four hours after 10 mg of procaine PEN/kg of body weight (IM), concentrations in mastitic milk equal to MIC or MBC were maintained only for Str dysgalactiae. Twenty-four hours after 20 mg of procaine PEN/kg (IM), MBC in mastitic milk was maintained for Str uberis and 50% of the S aureus. When concentrations equal to MIC or MBC Of PEN were combined with a sub-MIC amount of DHS, the in vitro synergistic killing of Str uberis was not observed in vivo. In agreement with in vitro killing effect at PEN concentrations equal to MBC, Str dysgalactiae was 100% eliminated in 5 cows when MBC of PEN in mastitic milk was maintained for 24 to 36 hours. On the contrary, only 2 of 6 cows inoculated with Str uberis were free of this pathogen, although MBC of PEN was maintained for 24 to 36 hours in mastitic milk.